Global Transient Protein Expression Market By Offering (Product (Kits and Reagent, Expression Vector, Competent Cells, Others), Services), By System Type (Mammalian, Insect, Yeast, Bacterial, Algal, Cell-Free), By Application (Vaccines Development, Intracellular & Multi-Protein Complexes, Structural Analysis, Protein Interaction, Antibody Production, Genetic Engineering, Functional Assays, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic and research institutes, Clinical Research Organizations), By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Protein expression is the process by which proteins in living organisms are synthesized, modified, and regulated. The term can refer to either the object of study or the laboratory techniques required to manufacture proteins in protein research. Transient expression systems, which have been developed and improved, have significantly reduced the time required for protein production and increased the yield of recombinant proteins in plants. Also, recombinant proteins are used to treat and prevent diseases in both humans and animals. In academic research, the production of recombinant proteins is also important for identifying protein functions and elucidating protein structure. The transfection technique is utilized for cancer research, plant and animal genomics, gene therapy, clinical research, and diagnostics. As there is a greater demand for cancer research and synthetic genes, the transient protein expression market will grow.
Advances in genetic science have played a key role in popularizing transient expression. The study of animal cells has been a priority in the field of zoology, providing new prospects for growth in the worldwide transient protein expression market. Furthermore, the market's main companies contribute to its growth by collaborating with other players. Jianshun Biosciences, for example, formed strategic cooperation with Etta Biotech in January 2021 to establish a high titer transient protein expression platform for the production of high-quality protein using JS Bio's transient transfection media. Etta Biotech's transient transfection high titer protein expression technology now has an exclusive cell culture source in JS Bio. JS Bio's sophisticated quality and service processes will speed the industry's acceptance of Etta Biotech's products in antibody drug development.
The World Health Organization declared COVID-19 a pandemic on March 11th, and it has caused millions of illnesses and a quarter million deaths since then. Clinical signs of this disease include pneumonia, lung problems, inflammation, and severe acute respiratory syndrome (SARS). The availability of recombinant versions of the SARS-CoV-2 spike protein, which is one of the crucial components for the development of innovative COVID-19 pandemic response strategies. The spike protein is a major antigen in the human immune response to the SARS coronavirus and is frequently the target of neutralizing antibodies detected in convalescent patients. Recombinant spike protein has numerous potential applications, including the creation of novel therapies, clinical diagnostic tools, and subunit vaccines. Furthermore, increased promise of innovation in the development of drugs and vaccines will, in the near future, promise new opportunities for market participants in the transient protein expression market to grow.
In terms of revenue, the transient protein expression market is growing at a CAGR of 15.34% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Transient Protein Expression Market Revenue & Forecast, (US$ Million), 2015 – 2030
Offering Outlook
The product segment of the global transient protein expression market accounted for a considerable share in 2021. Expression vector segment, under products category is projected to be the fastest emerging segment over the forecast period owing to increasing research and development activities and increasing applications of transient protein expression boosting for the segment growth. Furthermore, market participants produce products globally and contribute to market growth, such as Promega Corporation's pCI Mammalian Expression Vector, which increases the constitutive expression of cloned DNA inserts in mammalian cells. The pCI Expression vector shows the human cytomegalovirus (CMV) main immediate-early gene enhancer/promoter region. This vector can be used to express genes both transiently and permanently. The pCI Vector must be co-transfected with an expression vector encoding a selective gene for mammalian cells in order to achieve steady expression.
System Type Outlook
Based on system type, the global transient protein expression market has been classified into mammalian, insect, yeast, bacterial, algal, and cell-free. The insect system type is one of the fastest emerging segment over the forecast period. Insect cells can be utilized to synthesize complex eukaryotic proteins with appropriate post-translational modifications. The use of insect cell expression systems to produce recombinant proteins has significant advantages for the study of eukaryotic proteins. Insect cell systems also demand fewer resources, as well as less time and effort to maintain than mammalian cell lines. These are the variables that will propel the segment growth in the coming years.
Application Outlook
Based on application, the global transient protein expression market has been classified into vaccine development, intracellular & multi-protein complexes, structural analysis, protein interaction, antibody production, genetic engineering, functional assays, and others. The genetic engineering segment is one of the fastest emerging segments over the forecast period. The advancement of genetic engineering and cloning has created numerous opportunities for the expression and isolation of heterologous proteins for research purposes. Significant technological developments have permitted the large-scale production and isolation of recombinant proteins. Continuous advancement in protein expression system for genetic purposes will drive the segment growth over the forecast period.
End-User Outlook
Based on end-user, the global transient protein expression market has been divided into pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations. The pharmaceutical and biotechnology companies segment registered for the highest market share in 2021 due to increased spending on the development of new drugs, and vaccines in the recent decades.
Region Outlook:
Based on regions, Asia Pacific is predicted to grow at the quickest rate during the forecast period 2022 – 2030 owing to rising pharmaceutical spending for infrastructure improvements and increasing research and development (R&D) activities in the region. Major players are also increasing their presence in developing economies such as China and India, which will additionally contribute for the region's growth over the forecast period.
Competitive Landscape Outlook:
The report provides both, qualitative and quantitative research of global transient protein expression market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global transient protein expression market are
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- GenScript
- Merck KGaA
- Meridian
- New England Biolabs.
- PhyNexus, Inc.
- Promega Corporation
- Proteogenix
- Qiagen
- Sino Biological Inc.
- STEMCELL Technologies Inc.
- Takara Bio Inc.
- Thermo Fisher Scientific
- Other Market Participants
Global Transient Protein Expression Market:
- By Offering
- Product
- Kits and Reagent
- Expression Vector
- Competent Cells
- Others
- Services
- Product
- By System Type
- Mammalian
- Insect
- Yeast
- Bacterial
- Algal
- Cell-Free
- By Application
- Vaccines Development
- Intracellular & Multi-Protein Complexes
- Structural Analysis
- Protein Interaction
- Antibody Production
- Genetic Engineering
- Functional Assays
- Others
- By End Users
- Pharmaceutical and Biotechnology Companies
- Academic and research institutes
- Clinical Research Organizations
- By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2020
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 – 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Transient Protein Expression Market
6. Market Synopsis:
Transient Protein Expression Market
7. Transient Protein Expression Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
Transient Protein Expression Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Transient Protein Expression Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Transient Protein Expression Market
8. Global Transient Protein Expression Market Analysis and
Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global
Transient Protein Expression Market Revenue (US$ Mn)
8.2. Global
Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offering
8.2.1. Product
(Definition, Market Estimation and Penetration, 2015 - 2021, Market Estimation
(2015 - 2021), Market Forecast (2022 – 2030), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Kits and Reagent, Expression
Vector, Competent Cells, Others)
8.2.1.1. Kits and Reagent
8.2.1.2. Expression Vector
8.2.1.3. Competent Cells
8.2.1.4. Others
8.2.2. Services
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2021
8.2.2.3. Market Forecast, 2022 – 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2021
8.2.2.5.1.2. Market
Forecast, 2022 – 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2021
8.2.2.5.2.2. Market
Forecast, 2022 – 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2021
8.2.2.5.3.2. Market
Forecast, 2022 – 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2021
8.2.2.5.4.2. Market
Forecast, 2022 – 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2021
8.2.2.5.5.2. Market
Forecast, 2022 – 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offering
9. Global Transient Protein Expression Market Analysis and
Forecasts, 2022 – 2030
9.1. Overview
9.2. Global
Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By System
Type
9.2.1. Mammalian
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2021
9.2.1.3. Market Forecast, 2022 – 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022 – 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022 – 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022 – 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022 – 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022 – 2030
9.2.2. Insect
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2021
9.2.2.3. Market Forecast, 2022 – 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2021
9.2.2.5.1.2. Market
Forecast, 2022 – 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2021
9.2.2.5.2.2. Market
Forecast, 2022 – 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2021
9.2.2.5.3.2. Market
Forecast, 2022 – 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2021
9.2.2.5.4.2. Market
Forecast, 2022 – 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2021
9.2.2.5.5.2. Market
Forecast, 2022 – 2030
9.2.3. Yeast
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2021
9.2.3.3. Market Forecast, 2022 – 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2021
9.2.3.5.1.2. Market
Forecast, 2022 – 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2021
9.2.3.5.2.2. Market
Forecast, 2022 – 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2021
9.2.3.5.3.2. Market
Forecast, 2022 – 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2021
9.2.3.5.4.2. Market
Forecast, 2022 – 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2021
9.2.3.5.5.2. Market
Forecast, 2022 – 2030
9.2.4. Bacterial
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2021
9.2.4.3. Market Forecast, 2022 – 2030
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 - 2021
9.2.4.5.1.2. Market
Forecast, 2022 – 2030
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2021
9.2.4.5.2.2. Market
Forecast, 2022 – 2030
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2021
9.2.4.5.3.2. Market
Forecast, 2022 – 2030
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2021
9.2.4.5.4.2. Market
Forecast, 2022 – 2030
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 - 2021
9.2.4.5.5.2. Market
Forecast, 2022 – 2030
9.2.5. Algal
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 - 2021
9.2.5.3. Market Forecast, 2022 – 2030
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market
Estimation, 2015 - 2021
9.2.5.5.1.2. Market
Forecast, 2022 – 2030
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2021
9.2.5.5.2.2. Market
Forecast, 2022 – 2030
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2021
9.2.5.5.3.2. Market
Forecast, 2022 – 2030
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2021
9.2.5.5.4.2. Market
Forecast, 2022 – 2030
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market
Estimation, 2015 - 2021
9.2.5.5.5.2. Market
Forecast, 2022 – 2030
9.2.6. Cell-Free
9.2.6.1. Definition
9.2.6.2. Market Estimation and Penetration, 2015 - 2021
9.2.6.3. Market Forecast, 2022 – 2030
9.2.6.4. Compound Annual Growth Rate (CAGR)
9.2.6.5. Regional Bifurcation
9.2.6.5.1. North America
9.2.6.5.1.1. Market
Estimation, 2015 - 2021
9.2.6.5.1.2. Market
Forecast, 2022 – 2030
9.2.6.5.2. Europe
9.2.6.5.2.1. Market
Estimation, 2015 - 2021
9.2.6.5.2.2. Market
Forecast, 2022 – 2030
9.2.6.5.3. Asia Pacific
9.2.6.5.3.1. Market
Estimation, 2015 - 2021
9.2.6.5.3.2. Market
Forecast, 2022 – 2030
9.2.6.5.4. Middle East and Africa
9.2.6.5.4.1. Market
Estimation, 2015 - 2021
9.2.6.5.4.2. Market
Forecast, 2022 – 2030
9.2.6.5.5. Latin America
9.2.6.5.5.1. Market
Estimation, 2015 - 2021
9.2.6.5.5.2. Market
Forecast, 2022 – 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By
System Type
10. Global Transient Protein Expression Market Analysis and
Forecasts, 2022 – 2030
10.1. Overview
10.2. Global
Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
Application
10.2.1. Vaccines
Development
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2021
10.2.1.3. Market Forecast, 2022 – 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2021
10.2.1.5.1.2. Market
Forecast, 2022 – 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2021
10.2.1.5.2.2. Market
Forecast, 2022 – 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2021
10.2.1.5.3.2. Market
Forecast, 2022 – 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2021
10.2.1.5.4.2. Market
Forecast, 2022 – 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2021
10.2.1.5.5.2. Market
Forecast, 2022 – 2030
10.2.2. Intracellular
and Multi-Protein Complexes
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2021
10.2.2.3. Market Forecast, 2022 – 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2021
10.2.2.5.1.2. Market
Forecast, 2022 – 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2021
10.2.2.5.2.2. Market
Forecast, 2022 – 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2021
10.2.2.5.3.2. Market
Forecast, 2022 – 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2021
10.2.2.5.4.2. Market
Forecast, 2022 – 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2021
10.2.2.5.5.2. Market
Forecast, 2022 – 2030
10.2.3. Structural
Analysis
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2021
10.2.3.3. Market Forecast, 2022 – 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2021
10.2.3.5.1.2. Market
Forecast, 2022 – 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2021
10.2.3.5.2.2. Market
Forecast, 2022 – 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2021
10.2.3.5.3.2. Market
Forecast, 2022 – 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2021
10.2.3.5.4.2. Market
Forecast, 2022 – 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2021
10.2.3.5.5.2. Market
Forecast, 2022 – 2030
10.2.4. Protein
Interaction
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2021
10.2.4.3. Market Forecast, 2022 – 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2021
10.2.4.5.1.2. Market
Forecast, 2022 – 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2021
10.2.4.5.2.2. Market
Forecast, 2022 – 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2021
10.2.4.5.3.2. Market
Forecast, 2022 – 2030
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2021
10.2.4.5.4.2. Market
Forecast, 2022 – 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2021
10.2.4.5.5.2. Market
Forecast, 2022 – 2030
10.2.5. Antibody
Production
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 - 2021
10.2.5.3. Market Forecast, 2022 – 2030
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market
Estimation, 2015 - 2021
10.2.5.5.1.2. Market
Forecast, 2022 – 2030
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 - 2021
10.2.5.5.2.2. Market
Forecast, 2022 – 2030
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market
Estimation, 2015 - 2021
10.2.5.5.3.2. Market
Forecast, 2022 – 2030
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 - 2021
10.2.5.5.4.2. Market
Forecast, 2022 – 2030
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market
Estimation, 2015 - 2021
10.2.5.5.5.2. Market
Forecast, 2022 – 2030
10.2.6. Genetic
Engineering
10.2.6.1. Definition
10.2.6.2. Market Estimation and Penetration, 2015 - 2021
10.2.6.3. Market Forecast, 2022 – 2030
10.2.6.4. Compound Annual Growth Rate (CAGR)
10.2.6.5. Regional Bifurcation
10.2.6.5.1. North America
10.2.6.5.1.1. Market
Estimation, 2015 - 2021
10.2.6.5.1.2. Market
Forecast, 2022 – 2030
10.2.6.5.2. Europe
10.2.6.5.2.1. Market
Estimation, 2015 - 2021
10.2.6.5.2.2. Market
Forecast, 2022 – 2030
10.2.6.5.3. Asia Pacific
10.2.6.5.3.1. Market
Estimation, 2015 - 2021
10.2.6.5.3.2. Market
Forecast, 2022 – 2030
10.2.6.5.4. Middle East and Africa
10.2.6.5.4.1. Market
Estimation, 2015 - 2021
10.2.6.5.4.2. Market
Forecast, 2022 – 2030
10.2.6.5.5. Latin America
10.2.6.5.5.1. Market
Estimation, 2015 - 2021
10.2.6.5.5.2. Market
Forecast, 2022 – 2030
10.2.7. Functional
Assays
10.2.7.1. Definition
10.2.7.2. Market Estimation and Penetration, 2015 - 2021
10.2.7.3. Market Forecast, 2022 – 2030
10.2.7.4. Compound Annual Growth Rate (CAGR)
10.2.7.5. Regional Bifurcation
10.2.7.5.1. North America
10.2.7.5.1.1. Market
Estimation, 2015 - 2021
10.2.7.5.1.2. Market
Forecast, 2022 – 2030
10.2.7.5.2. Europe
10.2.7.5.2.1. Market
Estimation, 2015 - 2021
10.2.7.5.2.2. Market
Forecast, 2022 – 2030
10.2.7.5.3. Asia Pacific
10.2.7.5.3.1. Market
Estimation, 2015 - 2021
10.2.7.5.3.2. Market
Forecast, 2022 – 2030
10.2.7.5.4. Middle East and Africa
10.2.7.5.4.1. Market
Estimation, 2015 - 2021
10.2.7.5.4.2. Market
Forecast, 2022 – 2030
10.2.7.5.5. Latin America
10.2.7.5.5.1. Market
Estimation, 2015 - 2021
10.2.7.5.5.2. Market
Forecast, 2022 – 2030
10.2.8. Others
10.2.8.1. Definition
10.2.8.2. Market Estimation and Penetration, 2015 - 2021
10.2.8.3. Market Forecast, 2022 – 2030
10.2.8.4. Compound Annual Growth Rate (CAGR)
10.2.8.5. Regional Bifurcation
10.2.8.5.1. North America
10.2.8.5.1.1. Market
Estimation, 2015 - 2021
10.2.8.5.1.2. Market
Forecast, 2022 – 2030
10.2.8.5.2. Europe
10.2.8.5.2.1. Market
Estimation, 2015 - 2021
10.2.8.5.2.2. Market
Forecast, 2022 – 2030
10.2.8.5.3. Asia Pacific
10.2.8.5.3.1. Market
Estimation, 2015 - 2021
10.2.8.5.3.2. Market
Forecast, 2022 – 2030
10.2.8.5.4. Middle East and Africa
10.2.8.5.4.1. Market
Estimation, 2015 - 2021
10.2.8.5.4.2. Market
Forecast, 2022 – 2030
10.2.8.5.5. Latin America
10.2.8.5.5.1. Market
Estimation, 2015 - 2021
10.2.8.5.5.2. Market
Forecast, 2022 – 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By
Application
11. Global Transient Protein Expression Market Analysis and
Forecasts, 2022 – 2030
11.1. Overview
11.2. Global
Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User
11.2.1. Pharmaceutical
and Biotechnology Companies
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2021
11.2.1.3. Market Forecast, 2022 – 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2021
11.2.1.5.1.2. Market
Forecast, 2022 – 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2021
11.2.1.5.2.2. Market
Forecast, 2022 – 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2021
11.2.1.5.3.2. Market
Forecast, 2022 – 2030
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2021
11.2.1.5.4.2. Market
Forecast, 2022 – 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2021
11.2.1.5.5.2. Market
Forecast, 2022 – 2030
11.2.2. Academic
and research institutes
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2021
11.2.2.3. Market Forecast, 2022 – 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2021
11.2.2.5.1.2. Market
Forecast, 2022 – 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2021
11.2.2.5.2.2. Market
Forecast, 2022 – 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2021
11.2.2.5.3.2. Market
Forecast, 2022 – 2030
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2021
11.2.2.5.4.2. Market
Forecast, 2022 – 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2021
11.2.2.5.5.2. Market
Forecast, 2022 – 2030
11.2.3. Clinical
Research Organizations
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2021
11.2.3.3. Market Forecast, 2022 – 2030
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2021
11.2.3.5.1.2. Market
Forecast, 2022 – 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2021
11.2.3.5.2.2. Market
Forecast, 2022 – 2030
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2021
11.2.3.5.3.2. Market
Forecast, 2022 – 2030
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2021
11.2.3.5.4.2. Market
Forecast, 2022 – 2030
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2021
11.2.3.5.5.2. Market
Forecast, 2022 – 2030
11.3. Key
Segment for Channeling Investments
11.3.1. By End
User
12. North America Transient Protein Expression Market Analysis
and Forecasts, 2022 – 2030
12.1. Overview
12.1.1. North
America Transient Protein Expression Market Revenue (US$ Mn)
12.2. North
America Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
Offering
12.2.1. Product
12.2.1.1. Kits and Reagent
12.2.1.2. Expression Vector
12.2.1.3. Competent Cells
12.2.1.4. Others
12.2.2. Services
12.3. North
America Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
System Type
12.3.1. Mammalian
12.3.2. Insect
12.3.3. Yeast
12.3.4. Bacterial
12.3.5. Algal
12.3.6. Cell-Free
12.4. North
America Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.1. Vaccines
Development
12.4.2. Intracellular
and Multi-Protein Complexes
12.4.3. Structural
Analysis
12.4.4. Protein
Interaction
12.4.5. Antibody
Production
12.4.6. Genetic
Engineering
12.4.7. Functional
Assays
12.4.8. Others
12.5. North
America Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
End User
12.5.1. Pharmaceutical
and Biotechnology Companies
12.5.2. Academic
and research institutes
12.5.3. Clinical
Research Organizations
12.6. North
America Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
Country
12.6.1. U.S
12.6.1.1. U.S Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Offering
12.6.1.1.1. Product
12.6.1.1.1.1. Kits
and Reagent
12.6.1.1.1.2. Expression
Vector
12.6.1.1.1.3. Competent
Cells
12.6.1.1.1.4. Others
12.6.1.1.2. Services
12.6.1.2. U.S Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By System Type
12.6.1.2.1. Mammalian
12.6.1.2.2. Insect
12.6.1.2.3. Yeast
12.6.1.2.4. Bacterial
12.6.1.2.5. Algal
12.6.1.2.6. Cell-Free
12.6.1.3. U.S Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.1.3.1. Vaccines Development
12.6.1.3.2. Intracellular and Multi-Protein Complexes
12.6.1.3.3. Structural Analysis
12.6.1.3.4. Protein Interaction
12.6.1.3.5. Antibody Production
12.6.1.3.6. Genetic Engineering
12.6.1.3.7. Functional Assays
12.6.1.3.8. Others
12.6.1.4. U.S Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.1.4.1. Pharmaceutical and Biotechnology Companies
12.6.1.4.2. Academic and research institutes
12.6.1.4.3. Clinical Research Organizations
12.6.2. Canada
12.6.2.1. Canada Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Offering
12.6.2.1.1. Product
12.6.2.1.1.1. Kits
and Reagent
12.6.2.1.1.2. Expression
Vector
12.6.2.1.1.3. Competent
Cells
12.6.2.1.1.4. Others
12.6.2.1.2. Services
12.6.2.2. Canada Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By System Type
12.6.2.2.1. Mammalian
12.6.2.2.2. Insect
12.6.2.2.3. Yeast
12.6.2.2.4. Bacterial
12.6.2.2.5. Algal
12.6.2.2.6. Cell-Free
12.6.2.3. Canada Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Application
12.6.2.3.1. Vaccines Development
12.6.2.3.2. Intracellular and Multi-Protein Complexes
12.6.2.3.3. Structural Analysis
12.6.2.3.4. Protein Interaction
12.6.2.3.5. Antibody Production
12.6.2.3.6. Genetic Engineering
12.6.2.3.7. Functional Assays
12.6.2.3.8. Others
12.6.2.4. Canada Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By End User
12.6.2.4.1. Pharmaceutical and Biotechnology Companies
12.6.2.4.2. Academic and research institutes
12.6.2.4.3. Clinical Research Organizations
12.6.3. Mexico
12.6.3.1. Mexico Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Offering
12.6.3.1.1. Product
12.6.3.1.1.1. Kits
and Reagent
12.6.3.1.1.2. Expression
Vector
12.6.3.1.1.3. Competent
Cells
12.6.3.1.1.4. Others
12.6.3.1.2. Services
12.6.3.2. Mexico Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By System Type
12.6.3.2.1. Mammalian
12.6.3.2.2. Insect
12.6.3.2.3. Yeast
12.6.3.2.4. Bacterial
12.6.3.2.5. Algal
12.6.3.2.6. Cell-Free
12.6.3.3. Mexico Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Application
12.6.3.3.1. Vaccines Development
12.6.3.3.2. Intracellular and Multi-Protein Complexes
12.6.3.3.3. Structural Analysis
12.6.3.3.4. Protein Interaction
12.6.3.3.5. Antibody Production
12.6.3.3.6. Genetic Engineering
12.6.3.3.7. Functional Assays
12.6.3.3.8. Others
12.6.3.4. Mexico Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By End User
12.6.3.4.1. Pharmaceutical and Biotechnology Companies
12.6.3.4.2. Academic and research institutes
12.6.3.4.3. Clinical Research Organizations
12.6.4. Rest of
North America
12.6.4.1. Rest of North America Transient Protein Expression Market
Revenue (US$ Mn) and Forecasts, By Offering
12.6.4.1.1. Product
12.6.4.1.1.1. Kits
and Reagent
12.6.4.1.1.2. Expression
Vector
12.6.4.1.1.3. Competent
Cells
12.6.4.1.1.4. Others
12.6.4.1.2. Services
12.6.4.2. Rest of North America Transient Protein Expression Market
Revenue (US$ Mn) and Forecasts, By System Type
12.6.4.2.1. Mammalian
12.6.4.2.2. Insect
12.6.4.2.3. Yeast
12.6.4.2.4. Bacterial
12.6.4.2.5. Algal
12.6.4.2.6. Cell-Free
12.6.4.3. Rest of North America Transient Protein Expression Market
Revenue (US$ Mn) and Forecasts, By Application
12.6.4.3.1. Vaccines Development
12.6.4.3.2. Intracellular and Multi-Protein Complexes
12.6.4.3.3. Structural Analysis
12.6.4.3.4. Protein Interaction
12.6.4.3.5. Antibody Production
12.6.4.3.6. Genetic Engineering
12.6.4.3.7. Functional Assays
12.6.4.3.8. Others
12.6.4.4. Rest of North America Transient Protein Expression Market
Revenue (US$ Mn) and Forecasts, By End User
12.6.4.4.1. Pharmaceutical and Biotechnology Companies
12.6.4.4.2. Academic and research institutes
12.6.4.4.3. Clinical Research Organizations
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Offering
12.7.3. By
System Type
12.7.4. By
Application
12.7.5. By End
User
13. Europe Transient Protein Expression Market Analysis and
Forecasts, 2022 – 2030
13.1. Overview
13.1.1. Europe
Transient Protein Expression Market Revenue (US$ Mn)
13.2. Europe
Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offering
13.2.1. Product
13.2.1.1. Kits and Reagent
13.2.1.2. Expression Vector
13.2.1.3. Competent Cells
13.2.1.4. Others
13.2.2. Services
13.3. Europe
Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By System
Type
13.3.1. Mammalian
13.3.2. Insect
13.3.3. Yeast
13.3.4. Bacterial
13.3.5. Algal
13.3.6. Cell-Free
13.4. Europe
Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
Application
13.4.1. Vaccines
Development
13.4.2. Intracellular
and Multi-Protein Complexes
13.4.3. Structural
Analysis
13.4.4. Protein
Interaction
13.4.5. Antibody
Production
13.4.6. Genetic
Engineering
13.4.7. Functional
Assays
13.4.8. Others
13.5. Europe
Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User
13.5.1. Pharmaceutical
and Biotechnology Companies
13.5.2. Academic
and research institutes
13.5.3. Clinical
Research Organizations
13.6. Europe
Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Offering
13.6.1.1.1. Product
13.6.1.1.1.1. Kits
and Reagent
13.6.1.1.1.2. Expression
Vector
13.6.1.1.1.3. Competent
Cells
13.6.1.1.1.4. Others
13.6.1.1.2. Services
13.6.1.2. France Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By System Type
13.6.1.2.1. Mammalian
13.6.1.2.2. Insect
13.6.1.2.3. Yeast
13.6.1.2.4. Bacterial
13.6.1.2.5. Algal
13.6.1.2.6. Cell-Free
13.6.1.3. France Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Application
13.6.1.3.1. Vaccines Development
13.6.1.3.2. Intracellular and Multi-Protein Complexes
13.6.1.3.3. Structural Analysis
13.6.1.3.4. Protein Interaction
13.6.1.3.5. Antibody Production
13.6.1.3.6. Genetic Engineering
13.6.1.3.7. Functional Assays
13.6.1.3.8. Others
13.6.1.4. France Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By End User
13.6.1.4.1. Pharmaceutical and Biotechnology Companies
13.6.1.4.2. Academic and research institutes
13.6.1.4.3. Clinical Research Organizations
13.6.2. The UK
13.6.2.1. The UK Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Offering
13.6.2.1.1. Product
13.6.2.1.1.1. Kits
and Reagent
13.6.2.1.1.2. Expression
Vector
13.6.2.1.1.3. Competent
Cells
13.6.2.1.1.4. Others
13.6.2.1.2. Services
13.6.2.2. The UK Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By System Type
13.6.2.2.1. Mammalian
13.6.2.2.2. Insect
13.6.2.2.3. Yeast
13.6.2.2.4. Bacterial
13.6.2.2.5. Algal
13.6.2.2.6. Cell-Free
13.6.2.3. The UK Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Application
13.6.2.3.1. Vaccines Development
13.6.2.3.2. Intracellular and Multi-Protein Complexes
13.6.2.3.3. Structural Analysis
13.6.2.3.4. Protein Interaction
13.6.2.3.5. Antibody Production
13.6.2.3.6. Genetic Engineering
13.6.2.3.7. Functional Assays
13.6.2.3.8. Others
13.6.2.4. The UK Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By End User
13.6.2.4.1. Pharmaceutical and Biotechnology Companies
13.6.2.4.2. Academic and research institutes
13.6.2.4.3. Clinical Research Organizations
13.6.3. Spain
13.6.3.1. Spain Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.3.1.1. Product
13.6.3.1.1.1. Kits
and Reagent
13.6.3.1.1.2. Expression
Vector
13.6.3.1.1.3. Competent
Cells
13.6.3.1.1.4. Others
13.6.3.1.2. Services
13.6.3.2. Spain Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By System Type
13.6.3.2.1. Mammalian
13.6.3.2.2. Insect
13.6.3.2.3. Yeast
13.6.3.2.4. Bacterial
13.6.3.2.5. Algal
13.6.3.2.6. Cell-Free
13.6.3.3. Spain Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.3.3.1. Vaccines Development
13.6.3.3.2. Intracellular and Multi-Protein Complexes
13.6.3.3.3. Structural Analysis
13.6.3.3.4. Protein Interaction
13.6.3.3.5. Antibody Production
13.6.3.3.6. Genetic Engineering
13.6.3.3.7. Functional Assays
13.6.3.3.8. Others
13.6.3.4. Spain Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.3.4.1. Pharmaceutical and Biotechnology Companies
13.6.3.4.2. Academic and research institutes
13.6.3.4.3. Clinical Research Organizations
13.6.4. Germany
13.6.4.1. Germany Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Offering
13.6.4.1.1. Product
13.6.4.1.1.1. Kits
and Reagent
13.6.4.1.1.2. Expression
Vector
13.6.4.1.1.3. Competent
Cells
13.6.4.1.1.4. Others
13.6.4.1.2. Services
13.6.4.2. Germany Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By System Type
13.6.4.2.1. Mammalian
13.6.4.2.2. Insect
13.6.4.2.3. Yeast
13.6.4.2.4. Bacterial
13.6.4.2.5. Algal
13.6.4.2.6. Cell-Free
13.6.4.3. Germany Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Application
13.6.4.3.1. Vaccines Development
13.6.4.3.2. Intracellular and Multi-Protein Complexes
13.6.4.3.3. Structural Analysis
13.6.4.3.4. Protein Interaction
13.6.4.3.5. Antibody Production
13.6.4.3.6. Genetic Engineering
13.6.4.3.7. Functional Assays
13.6.4.3.8. Others
13.6.4.4. Germany Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By End User
13.6.4.4.1. Pharmaceutical and Biotechnology Companies
13.6.4.4.2. Academic and research institutes
13.6.4.4.3. Clinical Research Organizations
13.6.5. Italy
13.6.5.1. Italy Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.5.1.1. Product
13.6.5.1.1.1. Kits
and Reagent
13.6.5.1.1.2. Expression
Vector
13.6.5.1.1.3. Competent
Cells
13.6.5.1.1.4. Others
13.6.5.1.2. Services
13.6.5.2. Italy Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By System Type
13.6.5.2.1. Mammalian
13.6.5.2.2. Insect
13.6.5.2.3. Yeast
13.6.5.2.4. Bacterial
13.6.5.2.5. Algal
13.6.5.2.6. Cell-Free
13.6.5.3. Italy Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.5.3.1. Vaccines Development
13.6.5.3.2. Intracellular and Multi-Protein Complexes
13.6.5.3.3. Structural Analysis
13.6.5.3.4. Protein Interaction
13.6.5.3.5. Antibody Production
13.6.5.3.6. Genetic Engineering
13.6.5.3.7. Functional Assays
13.6.5.3.8. Others
13.6.5.4. Italy Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.5.4.1. Pharmaceutical and Biotechnology Companies
13.6.5.4.2. Academic and research institutes
13.6.5.4.3. Clinical Research Organizations
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By Offering
13.6.6.1.1. Product
13.6.6.1.1.1. Kits
and Reagent
13.6.6.1.1.2. Expression
Vector
13.6.6.1.1.3. Competent
Cells
13.6.6.1.1.4. Others
13.6.6.1.2. Services
13.6.6.2. Nordic Countries Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By System Type
13.6.6.2.1. Mammalian
13.6.6.2.2. Insect
13.6.6.2.3. Yeast
13.6.6.2.4. Bacterial
13.6.6.2.5. Algal
13.6.6.2.6. Cell-Free
13.6.6.3. Nordic Countries Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By Application
13.6.6.3.1. Vaccines Development
13.6.6.3.2. Intracellular and Multi-Protein Complexes
13.6.6.3.3. Structural Analysis
13.6.6.3.4. Protein Interaction
13.6.6.3.5. Antibody Production
13.6.6.3.6. Genetic Engineering
13.6.6.3.7. Functional Assays
13.6.6.3.8. Others
13.6.6.4. Nordic Countries Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By End User
13.6.6.4.1. Pharmaceutical and Biotechnology Companies
13.6.6.4.2. Academic and research institutes
13.6.6.4.3. Clinical Research Organizations
13.6.6.5. Nordic Countries Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.7.1.1. Product
13.6.7.1.1.1. Kits
and Reagent
13.6.7.1.1.2. Expression
Vector
13.6.7.1.1.3. Competent
Cells
13.6.7.1.1.4. Others
13.6.7.1.2. Services
13.6.7.2. Benelux Union Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By System Type
13.6.7.2.1. Mammalian
13.6.7.2.2. Insect
13.6.7.2.3. Yeast
13.6.7.2.4. Bacterial
13.6.7.2.5. Algal
13.6.7.2.6. Cell-Free
13.6.7.3. Benelux Union Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By Application
13.6.7.3.1. Vaccines Development
13.6.7.3.2. Intracellular and Multi-Protein Complexes
13.6.7.3.3. Structural Analysis
13.6.7.3.4. Protein Interaction
13.6.7.3.5. Antibody Production
13.6.7.3.6. Genetic Engineering
13.6.7.3.7. Functional Assays
13.6.7.3.8. Others
13.6.7.4. Benelux Union Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By End User
13.6.7.4.1. Pharmaceutical and Biotechnology Companies
13.6.7.4.2. Academic and research institutes
13.6.7.4.3. Clinical Research Organizations
13.6.7.5. Benelux Union Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By Offering
13.6.8.1.1. Product
13.6.8.1.1.1. Kits
and Reagent
13.6.8.1.1.2. Expression
Vector
13.6.8.1.1.3. Competent
Cells
13.6.8.1.1.4. Others
13.6.8.1.2. Services
13.6.8.2. Rest of Europe Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By System Type
13.6.8.2.1. Mammalian
13.6.8.2.2. Insect
13.6.8.2.3. Yeast
13.6.8.2.4. Bacterial
13.6.8.2.5. Algal
13.6.8.2.6. Cell-Free
13.6.8.3. Rest of Europe Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By Application
13.6.8.3.1. Vaccines Development
13.6.8.3.2. Intracellular and Multi-Protein Complexes
13.6.8.3.3. Structural Analysis
13.6.8.3.4. Protein Interaction
13.6.8.3.5. Antibody Production
13.6.8.3.6. Genetic Engineering
13.6.8.3.7. Functional Assays
13.6.8.3.8. Others
13.6.8.4. Rest of Europe Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By End User
13.6.8.4.1. Pharmaceutical and Biotechnology Companies
13.6.8.4.2. Academic and research institutes
13.6.8.4.3. Clinical Research Organizations
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By
Offering
13.7.3. By
System Type
13.7.4. By
Application
13.7.5. By End
User
14. Asia Pacific Transient Protein Expression Market Analysis and
Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Asia
Pacific Transient Protein Expression Market Revenue (US$ Mn)
14.2. Asia
Pacific Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
Offering
14.2.1. Product
14.2.1.1. Kits and Reagent
14.2.1.2. Expression Vector
14.2.1.3. Competent Cells
14.2.1.4. Others
14.2.2. Services
14.3. Asia
Pacific Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
System Type
14.3.1. Mammalian
14.3.2. Insect
14.3.3. Yeast
14.3.4. Bacterial
14.3.5. Algal
14.3.6. Cell-Free
14.4. Asia
Pacific Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
Application
14.4.1. Vaccines
Development
14.4.2. Intracellular
and Multi-Protein Complexes
14.4.3. Structural
Analysis
14.4.4. Protein
Interaction
14.4.5. Antibody
Production
14.4.6. Genetic
Engineering
14.4.7. Functional
Assays
14.4.8. Others
14.5. Asia
Pacific Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
End User
14.5.1. Pharmaceutical
and Biotechnology Companies
14.5.2. Academic
and research institutes
14.5.3. Clinical
Research Organizations
14.6. Asia
Pacific Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
Country
14.6.1. China
14.6.1.1. China Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.1.1.1. Product
14.6.1.1.1.1. Kits
and Reagent
14.6.1.1.1.2. Expression
Vector
14.6.1.1.1.3. Competent
Cells
14.6.1.1.1.4. Others
14.6.1.1.2. Services
14.6.1.2. China Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By System Type
14.6.1.2.1. Mammalian
14.6.1.2.2. Insect
14.6.1.2.3. Yeast
14.6.1.2.4. Bacterial
14.6.1.2.5. Algal
14.6.1.2.6. Cell-Free
14.6.1.3. China Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.1.3.1. Vaccines Development
14.6.1.3.2. Intracellular and Multi-Protein Complexes
14.6.1.3.3. Structural Analysis
14.6.1.3.4. Protein Interaction
14.6.1.3.5. Antibody Production
14.6.1.3.6. Genetic Engineering
14.6.1.3.7. Functional Assays
14.6.1.3.8. Others
14.6.1.4. China Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.1.4.1. Pharmaceutical and Biotechnology Companies
14.6.1.4.2. Academic and research institutes
14.6.1.4.3. Clinical Research Organizations
14.6.2. Japan
14.6.2.1. Japan Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.2.1.1. Product
14.6.2.1.1.1. Kits
and Reagent
14.6.2.1.1.2. Expression
Vector
14.6.2.1.1.3. Competent
Cells
14.6.2.1.1.4. Others
14.6.2.1.2. Services
14.6.2.2. Japan Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By System Type
14.6.2.2.1. Mammalian
14.6.2.2.2. Insect
14.6.2.2.3. Yeast
14.6.2.2.4. Bacterial
14.6.2.2.5. Algal
14.6.2.2.6. Cell-Free
14.6.2.3. Japan Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.2.3.1. Vaccines Development
14.6.2.3.2. Intracellular and Multi-Protein Complexes
14.6.2.3.3. Structural Analysis
14.6.2.3.4. Protein Interaction
14.6.2.3.5. Antibody Production
14.6.2.3.6. Genetic Engineering
14.6.2.3.7. Functional Assays
14.6.2.3.8. Others
14.6.2.4. Japan Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.2.4.1. Pharmaceutical and Biotechnology Companies
14.6.2.4.2. Academic and research institutes
14.6.2.4.3. Clinical Research Organizations
14.6.3. India
14.6.3.1. India Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.3.1.1. Product
14.6.3.1.1.1. Kits
and Reagent
14.6.3.1.1.2. Expression
Vector
14.6.3.1.1.3. Competent
Cells
14.6.3.1.1.4. Others
14.6.3.1.2. Services
14.6.3.2. India Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By System Type
14.6.3.2.1. Mammalian
14.6.3.2.2. Insect
14.6.3.2.3. Yeast
14.6.3.2.4. Bacterial
14.6.3.2.5. Algal
14.6.3.2.6. Cell-Free
14.6.3.3. India Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.3.3.1. Vaccines Development
14.6.3.3.2. Intracellular and Multi-Protein Complexes
14.6.3.3.3. Structural Analysis
14.6.3.3.4. Protein Interaction
14.6.3.3.5. Antibody Production
14.6.3.3.6. Genetic Engineering
14.6.3.3.7. Functional Assays
14.6.3.3.8. Others
14.6.3.4. India Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.3.4.1. Pharmaceutical and Biotechnology Companies
14.6.3.4.2. Academic and research institutes
14.6.3.4.3. Clinical Research Organizations
14.6.4. New
Zealand
14.6.4.1. New Zealand Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By Offering
14.6.4.1.1. Product
14.6.4.1.1.1. Kits
and Reagent
14.6.4.1.1.2. Expression
Vector
14.6.4.1.1.3. Competent
Cells
14.6.4.1.1.4. Others
14.6.4.1.2. Services
14.6.4.2. New Zealand Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By System Type
14.6.4.2.1. Mammalian
14.6.4.2.2. Insect
14.6.4.2.3. Yeast
14.6.4.2.4. Bacterial
14.6.4.2.5. Algal
14.6.4.2.6. Cell-Free
14.6.4.3. New Zealand Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By Application
14.6.4.3.1. Vaccines Development
14.6.4.3.2. Intracellular and Multi-Protein Complexes
14.6.4.3.3. Structural Analysis
14.6.4.3.4. Protein Interaction
14.6.4.3.5. Antibody Production
14.6.4.3.6. Genetic Engineering
14.6.4.3.7. Functional Assays
14.6.4.3.8. Others
14.6.4.4. New Zealand Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By End User
14.6.4.4.1. Pharmaceutical and Biotechnology Companies
14.6.4.4.2. Academic and research institutes
14.6.4.4.3. Clinical Research Organizations
14.6.5. Australia
14.6.5.1. Australia Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Offering
14.6.5.1.1. Product
14.6.5.1.1.1. Kits
and Reagent
14.6.5.1.1.2. Expression
Vector
14.6.5.1.1.3. Competent
Cells
14.6.5.1.1.4. Others
14.6.5.1.2. Services
14.6.5.2. Australia Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By System Type
14.6.5.2.1. Mammalian
14.6.5.2.2. Insect
14.6.5.2.3. Yeast
14.6.5.2.4. Bacterial
14.6.5.2.5. Algal
14.6.5.2.6. Cell-Free
14.6.5.3. Australia Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Application
14.6.5.3.1. Vaccines Development
14.6.5.3.2. Intracellular and Multi-Protein Complexes
14.6.5.3.3. Structural Analysis
14.6.5.3.4. Protein Interaction
14.6.5.3.5. Antibody Production
14.6.5.3.6. Genetic Engineering
14.6.5.3.7. Functional Assays
14.6.5.3.8. Others
14.6.5.4. Australia Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By End User
14.6.5.4.1. Pharmaceutical and Biotechnology Companies
14.6.5.4.2. Academic and research institutes
14.6.5.4.3. Clinical Research Organizations
14.6.6. South
Korea
14.6.6.1. South Korea Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By Offering
14.6.6.1.1. Product
14.6.6.1.1.1. Kits
and Reagent
14.6.6.1.1.2. Expression
Vector
14.6.6.1.1.3. Competent
Cells
14.6.6.1.1.4. Others
14.6.6.1.2. Services
14.6.6.2. South Korea Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By System Type
14.6.6.2.1. Mammalian
14.6.6.2.2. Insect
14.6.6.2.3. Yeast
14.6.6.2.4. Bacterial
14.6.6.2.5. Algal
14.6.6.2.6. Cell-Free
14.6.6.3. South Korea Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By Application
14.6.6.3.1. Vaccines Development
14.6.6.3.2. Intracellular and Multi-Protein Complexes
14.6.6.3.3. Structural Analysis
14.6.6.3.4. Protein Interaction
14.6.6.3.5. Antibody Production
14.6.6.3.6. Genetic Engineering
14.6.6.3.7. Functional Assays
14.6.6.3.8. Others
14.6.6.4. South Korea Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By End User
14.6.6.4.1. Pharmaceutical and Biotechnology Companies
14.6.6.4.2. Academic and research institutes
14.6.6.4.3. Clinical Research Organizations
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By Offering
14.6.7.1.1. Product
14.6.7.1.1.1. Kits
and Reagent
14.6.7.1.1.2. Expression
Vector
14.6.7.1.1.3. Competent
Cells
14.6.7.1.1.4. Others
14.6.7.1.2. Services
14.6.7.2. Southeast Asia Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By System Type
14.6.7.2.1. Mammalian
14.6.7.2.2. Insect
14.6.7.2.3. Yeast
14.6.7.2.4. Bacterial
14.6.7.2.5. Algal
14.6.7.2.6. Cell-Free
14.6.7.3. Southeast Asia Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.7.3.1. Vaccines Development
14.6.7.3.2. Intracellular and Multi-Protein Complexes
14.6.7.3.3. Structural Analysis
14.6.7.3.4. Protein Interaction
14.6.7.3.5. Antibody Production
14.6.7.3.6. Genetic Engineering
14.6.7.3.7. Functional Assays
14.6.7.3.8. Others
14.6.7.4. Southeast Asia Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By End User
14.6.7.4.1. Pharmaceutical and Biotechnology Companies
14.6.7.4.2. Academic and research institutes
14.6.7.4.3. Clinical Research Organizations
14.6.7.5. Southeast Asia Transient Protein Expression Market Revenue
(US$ Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific Transient Protein Expression Market
Revenue (US$ Mn) and Forecasts, By Offering
14.6.8.1.1. Product
14.6.8.1.1.1. Kits
and Reagent
14.6.8.1.1.2. Expression
Vector
14.6.8.1.1.3. Competent
Cells
14.6.8.1.1.4. Others
14.6.8.1.2. Services
14.6.8.2. Rest of Asia Pacific Transient Protein Expression Market
Revenue (US$ Mn) and Forecasts, By System Type
14.6.8.2.1. Mammalian
14.6.8.2.2. Insect
14.6.8.2.3. Yeast
14.6.8.2.4. Bacterial
14.6.8.2.5. Algal
14.6.8.2.6. Cell-Free
14.6.8.3. Rest of Asia Pacific Transient Protein Expression Market
Revenue (US$ Mn) and Forecasts, By Application
14.6.8.3.1. Vaccines Development
14.6.8.3.2. Intracellular and Multi-Protein Complexes
14.6.8.3.3. Structural Analysis
14.6.8.3.4. Protein Interaction
14.6.8.3.5. Antibody Production
14.6.8.3.6. Genetic Engineering
14.6.8.3.7. Functional Assays
14.6.8.3.8. Others
14.6.8.4. Rest of Asia Pacific Transient Protein Expression Market
Revenue (US$ Mn) and Forecasts, By End User
14.6.8.4.1. Pharmaceutical and Biotechnology Companies
14.6.8.4.2. Academic and research institutes
14.6.8.4.3. Clinical Research Organizations
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By
Offering
14.7.3. By
System Type
14.7.4. By
Application
14.7.5. By End
User
15. Middle East and Africa Transient Protein Expression Market
Analysis and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Middle
East and Africa Transient Protein Expression Market Revenue (US$ Mn)
15.2. Middle
East and Africa Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Offering
15.2.1. Product
15.2.1.1. Kits and Reagent
15.2.1.2. Expression Vector
15.2.1.3. Competent Cells
15.2.1.4. Others
15.2.2. Services
15.3. Middle
East and Africa Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By System Type
15.3.1. Mammalian
15.3.2. Insect
15.3.3. Yeast
15.3.4. Bacterial
15.3.5. Algal
15.3.6. Cell-Free
15.4. Middle
East and Africa Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Application
15.4.1. Vaccines
Development
15.4.2. Intracellular
and Multi-Protein Complexes
15.4.3. Structural
Analysis
15.4.4. Protein
Interaction
15.4.5. Antibody
Production
15.4.6. Genetic
Engineering
15.4.7. Functional
Assays
15.4.8. Others
15.5. Middle
East and Africa Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By End User
15.5.1. Pharmaceutical
and Biotechnology Companies
15.5.2. Academic
and research institutes
15.5.3. Clinical
Research Organizations
15.6. Middle
East and Africa Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By Offering
15.6.1.1.1. Product
15.6.1.1.1.1. Kits
and Reagent
15.6.1.1.1.2. Expression
Vector
15.6.1.1.1.3. Competent
Cells
15.6.1.1.1.4. Others
15.6.1.1.2. Services
15.6.1.2. Saudi Arabia Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By System Type
15.6.1.2.1. Mammalian
15.6.1.2.2. Insect
15.6.1.2.3. Yeast
15.6.1.2.4. Bacterial
15.6.1.2.5. Algal
15.6.1.2.6. Cell-Free
15.6.1.3. Saudi Arabia Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By Application
15.6.1.3.1. Vaccines Development
15.6.1.3.2. Intracellular and Multi-Protein Complexes
15.6.1.3.3. Structural Analysis
15.6.1.3.4. Protein Interaction
15.6.1.3.5. Antibody Production
15.6.1.3.6. Genetic Engineering
15.6.1.3.7. Functional Assays
15.6.1.3.8. Others
15.6.1.4. Saudi Arabia Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By End User
15.6.1.4.1. Pharmaceutical and Biotechnology Companies
15.6.1.4.2. Academic and research institutes
15.6.1.4.3. Clinical Research Organizations
15.6.2. UAE
15.6.2.1. UAE Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Offering
15.6.2.1.1. Product
15.6.2.1.1.1. Kits
and Reagent
15.6.2.1.1.2. Expression
Vector
15.6.2.1.1.3. Competent
Cells
15.6.2.1.1.4. Others
15.6.2.1.2. Services
15.6.2.2. UAE Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By System Type
15.6.2.2.1. Mammalian
15.6.2.2.2. Insect
15.6.2.2.3. Yeast
15.6.2.2.4. Bacterial
15.6.2.2.5. Algal
15.6.2.2.6. Cell-Free
15.6.2.3. UAE Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.2.3.1. Vaccines Development
15.6.2.3.2. Intracellular and Multi-Protein Complexes
15.6.2.3.3. Structural Analysis
15.6.2.3.4. Protein Interaction
15.6.2.3.5. Antibody Production
15.6.2.3.6. Genetic Engineering
15.6.2.3.7. Functional Assays
15.6.2.3.8. Others
15.6.2.4. UAE Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.2.4.1. Pharmaceutical and Biotechnology Companies
15.6.2.4.2. Academic and research institutes
15.6.2.4.3. Clinical Research Organizations
15.6.3. Egypt
15.6.3.1. Egypt Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Offering
15.6.3.1.1. Product
15.6.3.1.1.1. Kits
and Reagent
15.6.3.1.1.2. Expression
Vector
15.6.3.1.1.3. Competent
Cells
15.6.3.1.1.4. Others
15.6.3.1.2. Services
15.6.3.2. Egypt Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By System Type
15.6.3.2.1. Mammalian
15.6.3.2.2. Insect
15.6.3.2.3. Yeast
15.6.3.2.4. Bacterial
15.6.3.2.5. Algal
15.6.3.2.6. Cell-Free
15.6.3.3. Egypt Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.3.3.1. Vaccines Development
15.6.3.3.2. Intracellular and Multi-Protein Complexes
15.6.3.3.3. Structural Analysis
15.6.3.3.4. Protein Interaction
15.6.3.3.5. Antibody Production
15.6.3.3.6. Genetic Engineering
15.6.3.3.7. Functional Assays
15.6.3.3.8. Others
15.6.3.4. Egypt Transient Protein Expression Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.3.4.1. Pharmaceutical and Biotechnology Companies
15.6.3.4.2. Academic and research institutes
15.6.3.4.3. Clinical Research Organizations
15.6.4. Kuwait
15.6.4.1. Kuwait Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Offering
15.6.4.1.1. Product
15.6.4.1.1.1. Kits
and Reagent
15.6.4.1.1.2. Expression
Vector
15.6.4.1.1.3. Competent
Cells
15.6.4.1.1.4. Others
15.6.4.1.2. Services
15.6.4.2. Kuwait Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By System Type
15.6.4.2.1. Mammalian
15.6.4.2.2. Insect
15.6.4.2.3. Yeast
15.6.4.2.4. Bacterial
15.6.4.2.5. Algal
15.6.4.2.6. Cell-Free
15.6.4.3. Kuwait Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Application
15.6.4.3.1. Vaccines Development
15.6.4.3.2. Intracellular and Multi-Protein Complexes
15.6.4.3.3. Structural Analysis
15.6.4.3.4. Protein Interaction
15.6.4.3.5. Antibody Production
15.6.4.3.6. Genetic Engineering
15.6.4.3.7. Functional Assays
15.6.4.3.8. Others
15.6.4.4. Kuwait Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By End User
15.6.4.4.1. Pharmaceutical and Biotechnology Companies
15.6.4.4.2. Academic and research institutes
15.6.4.4.3. Clinical Research Organizations
15.6.5. South
Africa
15.6.5.1. South Africa Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By Offering
15.6.5.1.1. Product
15.6.5.1.1.1. Kits
and Reagent
15.6.5.1.1.2. Expression
Vector
15.6.5.1.1.3. Competent
Cells
15.6.5.1.1.4. Others
15.6.5.1.2. Services
15.6.5.2. South Africa Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By System Type
15.6.5.2.1. Mammalian
15.6.5.2.2. Insect
15.6.5.2.3. Yeast
15.6.5.2.4. Bacterial
15.6.5.2.5. Algal
15.6.5.2.6. Cell-Free
15.6.5.3. South Africa Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By Application
15.6.5.3.1. Vaccines Development
15.6.5.3.2. Intracellular and Multi-Protein Complexes
15.6.5.3.3. Structural Analysis
15.6.5.3.4. Protein Interaction
15.6.5.3.5. Antibody Production
15.6.5.3.6. Genetic Engineering
15.6.5.3.7. Functional Assays
15.6.5.3.8. Others
15.6.5.4. South Africa Transient Protein Expression Market Revenue (US$
Mn) and Forecasts, By End User
15.6.5.4.1. Pharmaceutical and Biotechnology Companies
15.6.5.4.2. Academic and research institutes
15.6.5.4.3. Clinical Research Organizations
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Transient Protein Expression
Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.6.1.1. Product
15.6.6.1.1.1. Kits
and Reagent
15.6.6.1.1.2. Expression
Vector
15.6.6.1.1.3. Competent
Cells
15.6.6.1.1.4. Others
15.6.6.1.2. Services
15.6.6.2. Rest of Middle East & Africa Transient Protein Expression Market
Revenue (US$ Mn) and Forecasts, By System Type
15.6.6.2.1. Mammalian
15.6.6.2.2. Insect
15.6.6.2.3. Yeast
15.6.6.2.4. Bacterial
15.6.6.2.5. Algal
15.6.6.2.6. Cell-Free
15.6.6.3. Rest of Middle East & Africa Transient Protein Expression
Market Revenue (US$ Mn) and Forecasts, By Application
15.6.6.3.1. Vaccines Development
15.6.6.3.2. Intracellular and Multi-Protein Complexes
15.6.6.3.3. Structural Analysis
15.6.6.3.4. Protein Interaction
15.6.6.3.5. Antibody Production
15.6.6.3.6. Genetic Engineering
15.6.6.3.7. Functional Assays
15.6.6.3.8. Others
15.6.6.4. Rest of Middle East & Africa Transient Protein Expression
Market Revenue (US$ Mn) and Forecasts, By End User
15.6.6.4.1. Pharmaceutical and Biotechnology Companies
15.6.6.4.2. Academic and research institutes
15.6.6.4.3. Clinical Research Organizations
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Offering
15.7.3. By
System Type
15.7.4. By
Application
15.7.5. By End
User
16. Latin America Transient Protein Expression Market Analysis
and Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Latin
America Transient Protein Expression Market Revenue (US$ Mn)
16.2. Latin
America Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
Offering
16.2.1. Product
16.2.1.1. Kits and Reagent
16.2.1.2. Expression Vector
16.2.1.3. Competent Cells
16.2.1.4. Others
16.2.2. Services
16.3. Latin
America Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
System Type
16.3.1. Mammalian
16.3.2. Insect
16.3.3. Yeast
16.3.4. Bacterial
16.3.5. Algal
16.3.6. Cell-Free
16.4. Latin
America Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
Application
16.4.1. Vaccines
Development
16.4.2. Intracellular
and Multi-Protein Complexes
16.4.3. Structural
Analysis
16.4.4. Protein
Interaction
16.4.5. Antibody
Production
16.4.6. Genetic
Engineering
16.4.7. Functional
Assays
16.4.8. Others
16.5. Latin
America Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
End User
16.5.1. Pharmaceutical
and Biotechnology Companies
16.5.2. Academic
and research institutes
16.5.3. Clinical
Research Organizations
16.6. Latin
America Transient Protein Expression Market Revenue (US$ Mn) and Forecasts, By
Country
16.6.1. Brazil
16.6.1.1. Brazil Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Offering
16.6.1.1.1. Product
16.6.1.1.1.1. Kits
and Reagent
16.6.1.1.1.2. Expression
Vector
16.6.1.1.1.3. Competent
Cells
16.6.1.1.1.4. Others
16.6.1.1.2. Services
16.6.1.2. Brazil Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By System Type
16.6.1.2.1. Mammalian
16.6.1.2.2. Insect
16.6.1.2.3. Yeast
16.6.1.2.4. Bacterial
16.6.1.2.5. Algal
16.6.1.2.6. Cell-Free
16.6.1.3. Brazil Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Application
16.6.1.3.1. Vaccines Development
16.6.1.3.2. Intracellular and Multi-Protein Complexes
16.6.1.3.3. Structural Analysis
16.6.1.3.4. Protein Interaction
16.6.1.3.5. Antibody Production
16.6.1.3.6. Genetic Engineering
16.6.1.3.7. Functional Assays
16.6.1.3.8. Others
16.6.1.4. Brazil Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By End User
16.6.1.4.1. Pharmaceutical and Biotechnology Companies
16.6.1.4.2. Academic and research institutes
16.6.1.4.3. Clinical Research Organizations
16.6.2. Argentina
16.6.2.1. Argentina Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Offering
16.6.2.1.1. Product
16.6.2.1.1.1. Kits
and Reagent
16.6.2.1.1.2. Expression
Vector
16.6.2.1.1.3. Competent
Cells
16.6.2.1.1.4. Others
16.6.2.1.2. Services
16.6.2.2. Argentina Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By System Type
16.6.2.2.1. Mammalian
16.6.2.2.2. Insect
16.6.2.2.3. Yeast
16.6.2.2.4. Bacterial
16.6.2.2.5. Algal
16.6.2.2.6. Cell-Free
16.6.2.3. Argentina Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By Application
16.6.2.3.1. Vaccines Development
16.6.2.3.2. Intracellular and Multi-Protein Complexes
16.6.2.3.3. Structural Analysis
16.6.2.3.4. Protein Interaction
16.6.2.3.5. Antibody Production
16.6.2.3.6. Genetic Engineering
16.6.2.3.7. Functional Assays
16.6.2.3.8. Others
16.6.2.4. Argentina Transient Protein Expression Market Revenue (US$ Mn)
and Forecasts, By End User
16.6.2.4.1. Pharmaceutical and Biotechnology Companies
16.6.2.4.2. Academic and research institutes
16.6.2.4.3. Clinical Research Organizations
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America Transient Protein Expression Market
Revenue (US$ Mn) and Forecasts, By Offering
16.6.3.1.1. Product
16.6.3.1.1.1. Kits
and Reagent
16.6.3.1.1.2. Expression
Vector
16.6.3.1.1.3. Competent
Cells
16.6.3.1.1.4. Others
16.6.3.1.2. Services
16.6.3.2. Rest of Latin America Transient Protein Expression Market
Revenue (US$ Mn) and Forecasts, By System Type
16.6.3.2.1. Mammalian
16.6.3.2.2. Insect
16.6.3.2.3. Yeast
16.6.3.2.4. Bacterial
16.6.3.2.5. Algal
16.6.3.2.6. Cell-Free
16.6.3.3. Rest of Latin America Transient Protein Expression Market
Revenue (US$ Mn) and Forecasts, By Application
16.6.3.3.1. Vaccines Development
16.6.3.3.2. Intracellular and Multi-Protein Complexes
16.6.3.3.3. Structural Analysis
16.6.3.3.4. Protein Interaction
16.6.3.3.5. Antibody Production
16.6.3.3.6. Genetic Engineering
16.6.3.3.7. Functional Assays
16.6.3.3.8. Others
16.6.3.4. Rest of Latin America Transient Protein Expression Market
Revenue (US$ Mn) and Forecasts, By End User
16.6.3.4.1. Pharmaceutical and Biotechnology Companies
16.6.3.4.2. Academic and research institutes
16.6.3.4.3. Clinical Research Organizations
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Offering
16.7.3. By
System Type
16.7.4. By
Application
16.7.5. By End
User
17. Competitive Benchmarking
17.1. Brand
Benchmarking
17.2. Market
Share Analysis, 2021
17.3. Global
Presence and Growth Strategies
17.3.1. Mergers
and Acquisitions
17.3.2. Product
Launches
17.3.3. Investments
Trends
17.3.4. R&D
Initiatives
18. Player Profiles
18.1. Agilent
Technologies, Inc.
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. Bio-Rad
Laboratories, Inc.
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business Strategies
18.3. GenScript
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business Strategies
18.4. Merck KGaA
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business Strategies
18.5. Meridian
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business Strategies
18.6. New England Biolabs.
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business Strategies
18.7. PhyNexus, Inc.
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business Strategies
18.8. Promega Corporation
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business Strategies
18.9. Proteogenix
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business Strategies
18.10. Qiagen
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business Strategies
18.11. Sino Biological Inc.
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business Strategies
18.12. STEMCELL Technologies Inc.
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business Strategies
18.13. Takara Bio Inc.
18.13.1. Company
Details
18.13.2. Company
Overview
18.13.3. Product
Offerings
18.13.4. Key
Developments
18.13.5. Financial
Analysis
18.13.6. SWOT
Analysis
18.13.7. Business Strategies
18.14. Thermo Fisher Scientific
18.14.1. Company
Details
18.14.2. Company
Overview
18.14.3. Product
Offerings
18.14.4. Key
Developments
18.14.5. Financial
Analysis
18.14.6. SWOT
Analysis
18.14.7. Business Strategies
18.15. Other Market Participants
19. Key Findings
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
